Evidence map›Paper›PMID 31064407›Full record

ArticleJournal of medical case reports2019

Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report.

Julio Cesar Garcia Casallas, H Robayo-Amortegui, Z Corredor-Rozo, A M Carrasco-Márquez, Javier Escobar-Perez

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Colistin Resistance inAntibiotics (Basel, Switzerland) · 2023
    Review
  5. The Changes in Epidemiology of Imipenem-ResistantJournal of Korean medical science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Julio Cesar Garcia CasallasFacultad de Medicina, Evidence Therapeutic Group, Universidad de La Sabana, Campus Universitario, Km 7, Vía La Caro, Autopista Norte, Chía, Cundinamarca, Colombia. julio.garcia@unisabana.edu.co.
H Robayo-AmorteguiFacultad de Medicina, Evidence Therapeutic Group, Universidad de La Sabana, Campus Universitario, Km 7, Vía La Caro, Autopista Norte, Chía, Cundinamarca, Colombia.
Z Corredor-RozoBacterial Molecular Genetics Laboratory, Universidad El Bosque, Bogotá DC, Colombia.
A M Carrasco-MárquezCritic Medicine and Intensive Care Resident, Universidad de La Sabana, Chía, Cundinamarca, Colombia.
Javier Escobar-PerezBacterial Molecular Genetics Laboratory, Universidad El Bosque, Bogotá DC, Colombia.
Universidad de La Sabana · COUniversidad El Bosque · CO

Funding

Departamento Administrativo de Ciencia, Tecnología e Innovación (CO) El Bosque University PCI-2014-63 and Administrative Department of Science, Technology and Innovation/Colciencias grant 1308-71250819.universidad el bosque El Bosque University PCI-2014-63
6 · The paper itself

Abstract

backgroundCarbapenem-resistant Acinetobacter baumannii infections are a major public health problem worldwide, requiring the use of "old" antibiotics such as polymyxin B and E (colistin). However, there is concern regarding the emergence of isolates resistant to these antibiotics. CASE PRESENTATION: We report a case of a 64-year-old mestizo man hospitalized in an intensive care unit of a health institution in Colombia with identification and clinical and molecular typing of a colistin- and carbapenem-resistant A. baumannii isolate with mechanisms of resistance to colistin not previously reported, causing bacteremia.

conclusionsWe have identified a strain of A. baumannii with mechanisms of resistance to colistin not previously reported in a patient with bacteremia who required treatment with multiple antibiotic schemes and had an adequate response.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAgedAnti-Bacterial AgentsBacteremiaCatheter-Related InfectionsCatheters, IndwellingColistinDrug Resistance, Multiple, BacterialHumansMaleMiddle AgedAnti-Bacterial AgentsColistinAcinetobacter baumanniiBacteremiabla OXA-23Colistin resistanceColombia

Identifiers

PMID31064407
PMCPMC6505100
OpenAlexW2943862391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.